ABSTRACT Serum angiotensin converting enzyme activity is increased in many patients with pulmonary sarcoidosis and has been proposed as a measure of disease activity. Assay of serum angiotensin converting enzyme, bronchoalveolar lavage, and gallium scans were performed in 27 patients with biopsy proved pulmonary sarcoidosis. There was a positive correlation between serum angiotensin converting enzyme activity and an index of pulmonary gallium uptake assessed by the National Institutes of Health method (r = 0.7, p < 0.001). There was no significant relationship (r = 0.19) between serum angiotensin converting enzyme activity and bronchoalveolar lavage lymphocytes expressed as a proportion of cells recovered. Increase in the enzyme activity had a sensitivity of 50% as a means of detecting high intensity alveolitis but specificity was only 45%. There was no significant difference in mean angiotensin converting enzyme activity between the following groups: (1) those with positive and those with negative gallium scans; (2) those with bronchoalveolar lavage lymphocyte counts less than or equal to 28% and those with counts greater than 28%. Although there was a significant correlation between the enzyme activity and one component of the alveolitis of sarcoidosis, the data suggest that serum angiotensin converting enzyme activity alone is neither sensitive nor specific enough for high intensity alveolitis.
Since the observation by Lieberman in 1975 that serum angiotensin converting enzyme activity was increased in patients with pulmonary sarcoidosis,' many investigations have confirmed these findings2-but differed in their conclusions with respect to the utility of measurements of the enzyme in predicting disease activity. This conflict may be due in part to a lack of uniformity in the selection of the ancillary tests used to identify and quantify the active alveolitic component that precedes permanent structural derangement.'0 Studies on the natural history of pulmonary sarcoidosis have shown that most patients improve spontaneously with minimal or no impairment of lung function, 20-25% experience appreciable deterioration in pulmonary function, and 5-10% eventually die from the disease."-'3 Conventional criteria used in the assessment of disease activity, such as clinical features, chest radiographic appearances and results of pulmonary function tests, are insensitive markers of the alveolitis that characterises active disease and abnormalities usually reflect irreversible changes in lung structure and function due to progressive interstitial fibrosis and derangement of alveolar-capillary units.'4 1 ' The cellular derangements in sarcoidosis have been studied intensively; current understanding emphasises the dual cellular nature of the process, both activated T lymphocytes and alveolar macrophages being crucial to the initiation and perpetuation of alveolitis.'6 1" Recently Crystal et al have shown that only patients with "high intensity" alveolitis, as defined by a lavage T cell count greater than or equal to 28% of cells recovered and a positive gallium scan, were at risk for subsequent deterioration in pulmonary function.'0 Given the limitations of physiological measurement as a means of assessing the alveolitis, emphasis has been placed on analysis of lymphocytes harvested at bronchoalveolar lavage and uptake of gallium 67 by alveolar macrophages in assessing each component of the inflammatory response.'6 The 498 present study was undertaken to examine the relationship of serum angiotensin converting enzyme activity to each of these components and to determine its sensitivity and specificity as an indicator of abnormal results.
Methods
The study population consisted of 27 patients with biopsy proved pulmonary sarcoidosis with a mean age of 49.7 (SD 14.2) years. There were 15 women and 12 men. Twenty three (85%) were untreated at the time of entry into the study, or had not taken prednisone for a minimum of three months before being studied; four patients were taking prednisone. One patient was at radiographic stage 0 (normal chest film), three were at stage I (hilar adenopathy only), 11 were at stage II (hilar adenopathy and pulmonary infiltrates), and 12 were at stage III (pulmonary infiltrates only).
ANGIOTENSIN CONVERTING ENZYME Serum angiotensin converting enzyme was measured by the method of Friedland and Silverstein.'8 The substrate used was hippuryl-histidyl-leucine, which is hydrolysed by the enzyme to hippuric acid and histidyl-leucine. The latter is reacted with an orthophthaldialdehyde to produce a fluorescent product. Enzyme activity was measured as a function of the fluorescence with excitation at 360 nm and emission at 500 nm. Blood was taken from patients within seven days of the gallium scan and the serum separated immediately and stored frozen until assayed within 14 days. Our reference range for the assay is 12-52 units/litre, which is similar to that described by Friedland In the study group of 27 patients only the initial data from each of the 23 untreated patients were considered in examining the correlation between angiotensin converting enzyme activity and NIH index, and between enzyme activity and bronchoalveolar lavage lymphocyte differential count. In determining the sensitivity and specificity of serum angiotensin converting enzyme activity as a means of detecting high intensity alveolitis, only the data from untreated patients were considered. Correlation between the serum enzyme activity and the NIH index was determined by application of the Spearman Rank test, and between the enzyme activity and bronchoalveolar lavage lymphocyte differential count by the method of least squares regression analysis. The significance of differences between mean angiotensin converting enzyme values was determined by means of a two tailed t test.
Results
Comparison of serum angiotensin converting enzyme activity with gallium uptake as assessed by the NIH index showed a significant positive correlation between these two variables (r = 0.7, p < 0.001; fig 1) . There was no significant correlation between serum angiotensin converting enzyme activity and bronchoalveolar lavage lymphocytes, 
